Drug profile · INN
bexarotene
TARGRETIN
- US status
- approved
- Patents linked
- 1
- News articles
- 0
Quick answer
bexarotene (TARGRETIN) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
Key facts
INN bexarotene
Brand TARGRETIN
Route TOPICAL
Formulation CAPSULE
ATC code L01XF03
Originator Amneal Pharma Europe Ltd
Related patents
Search patents →Frequently asked questions
What is bexarotene?
bexarotene (TARGRETIN) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for bexarotene?
TARGRETIN is a marketed brand name for bexarotene. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of bexarotene?
bexarotene has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.